General Enquiries For General enquiries please email:UKandIEComms@takeda.com Map & Directions Medical Information If you are a member of the public requiring advice or information on your own medical condition or treatment please contact your own doctor or NHS Choices in the first instance. Our me...
Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do. We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to...
Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do. We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to...
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. BECOME A PREMIUM SUBSCRIBER ENDPOINTS CAREERS Executive Director, Marketing Celldex Therapeutics Hampton, NJ, USA view job offerpost your job now...
Takeda is leaning into a science-centric R&D campaign to help raise its profile in the US. The Japan-based pharma launched “Where Science Is” last year from its R&D communications group ...
Careers Contact Us Account Account Login Manage My Portfolio Privacy Create Portfolio Portfolio Health Check Alert Preferences Subscriptions Premium & Pro About Premium Group Subscriptions Alpha Picks About Alpha Picks FREE Newsletters Investing Groups Learn About Investing Groups Most P...
Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do. We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to...
Gilead stock slips as HHS denies reports of HIV funding cuts March 19, 2025 Pfizer fully exits Sensodyne maker Haleon in $3.3B stake sale March 19, 2025ENDPOINTS CAREERS Vice President, Biology & Translational Research Gondolabio Palo ...
Back in January, Takeda won approval for a new indication for its primary immunodeficiency drug HyQvia, this time as a treatment for a rare autoimmune disorder called chronic inflammatory demyelinating ...
Takeda and Hutchmed scored a priority review Thursday afternoon for a colorectal cancer drug, the companies announced. The experimental drug in question is fruquintinib, previously … ...